Comparison of intravitreal ranibizumab between phakic and pseudophakic neovascular age-related macular degeneration patients: Two-year results
Background and objective: To compare the efficacy of intravitreal ranibizumab (IVR) for the treatment of neovascular age-related macular degeneration (nAMD) between phakic and pseudophakic eyes after a follow-up of two years. Materials and methods: Data were analyzed retrospectively. The newly diagn...
Main Authors: | Abdullah Ozkaya, Zeynep Alkin, Ihsan Yilmaz, Ahmet Taylan Yazici |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-07-01
|
Series: | Saudi Journal of Ophthalmology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319453414001453 |
Similar Items
-
The Role of Epiretinal Membrane on Treatment of Neovascular Age-Related Macular Degeneration with Intravitreal Bevacizumab
by: Zeynep Alkin, et al.
Published: (2013-01-01) -
Is Spectral-Domain Optical Coherence Tomography Essential for Flexible Treatment Regimens with Ranibizumab for Neovascular Age-Related Macular Degeneration?
by: Abdullah Ozkaya, et al.
Published: (2013-01-01) -
Intravitreal Ranibizumab Therapy in Wet Type Macular Degeneration
by: Hüseyin Dündar, et al.
Published: (2014-10-01) -
Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01) -
Intravitreal Ranibizumab for Diabetic Macular Edema Patients with Good Baseline Visual Acuity: A Real-Life Study
by: Abdullah Ozkaya, et al.
Published: (2017-10-01)